Tau Screening Study in Subjects With Early Symptomatic AD

PHASE2CompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

March 8, 2018

Primary Completion Date

November 15, 2018

Study Completion Date

November 15, 2018

Conditions
Alzheimer Disease
Interventions
DRUG

Flortaucipir F18

370 megabecquerel (MBq) IV single-dose

PROCEDURE

Brain PET Scan

positron emission tomography (PET) scan of the brain

Trial Locations (9)

32127

Progressive Medical Research, Port Orange

32806

BioClinica Research, Orlando

33445

Brain Matters Research, Delray Beach

33912

Neuropsychiatric Research Center of Southwest Florida, Fort Myers

34470

Renstar Medical Research, Ocala

60640

Great Lakes Clinical Trials, Chicago

66606

Cotton O'neil Clinical Research Center, Topeka

92614

Irvine Center for Clinical Research, Irvine

02906

Butler Hospital, Providence

Sponsors
All Listed Sponsors
lead

Avid Radiopharmaceuticals

INDUSTRY